RegeneRx Biopharmaceuticals, Inc.
RegeneRx Biopharmaceuticals, Inc. (RGRX) Revenue
Annual & quarterly revenue history · segment & region breakdown
RGRX · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsRegeneRx Biopharmaceuticals, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income RegeneRx Biopharmaceuticals, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
RegeneRx Biopharmaceuticals, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from RegeneRx Biopharmaceuticals, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
RGRX revenue · 4 questionsRGRX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · RegeneRx Biopharmaceuticals, Inc. SEC filings · GAAP · RegeneRx Biopharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026